Neoadjuvant endocrine therapy expands stromal populations that predict poor prognosis in estrogen receptor‐positive breast cancer.

Autor: Brechbuhl, Heather M., Xie, Mengyu, Kopin, Etana G., Han, Amy L., Vinod‐Paul, Kiran, Hagen, Jaime, Edgerton, Susan, Owens, Philip, Sams, Sharon, Elias, Anthony, Sartorius, Carol A., Tan, Aik‐Choon, Kabos, Peter
Zdroj: Molecular Carcinogenesis; Mar2022, Vol. 61 Issue 3, p359-371, 13p
Databáze: Complementary Index
Externí odkaz: